CD90.2 / Thy-1.2 Antikörper (Biotin)

Produktnummer ABIN2660852

Dieser Ratte Monoklonal Antikörper erkennt spezifisch CD90.2 / Thy-1.2 in FACS, WB, IP und ELISA. Er zeigt eine Reaktivität gegenüber Maus.

Kurzübersicht für CD90.2 / Thy-1.2 Antikörper (Biotin) (ABIN2660852)

Target: CD90.2 / Thy-1.2

Reaktivität: Maus

Wirt: Ratte

Klonalität: Monoklonal

Konjugat: Dieser CD90.2 / Thy-1.2 Antikörper ist konjugiert mit Biotin

Applikation: Flow Cytometry (FACS), Western Blotting (WB), Immunoprecipitation (IP), ELISA

Klon: 53-2-1

Produktdetails anti-CD90.2 / Thy-1.2 Antikörper (Biotin)

Kreuzreaktivität (Details): Does not react with Thy-1.1 (CD90.1)

Aufreinigung: The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions. The solution is free of unconjugated biotin.

Isotyp: IgG2a kappa

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 0.5 mg/mL

Buffer: Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Protect from prolonged exposure to light. Do not freeze.

Lagerung: 4 °C

Informationen zur Lagerung: The antibody solution should be stored undiluted between 2°C and 8°C.

Details zu CD90.2 / Thy-1.2

Target: CD90.2 / Thy-1.2

Andere Bezeichnung: CD90.2

Hintergrund: CD90.2 is a 25-35 kD immunoglobulin superfamily member also known as Thy-1.2, a GPI-linked membrane molecule. It is expressed on hematopoietic stem cells and neurons, all thymocytes, and peripheral T cells in Thy1.2 bearing mouse strains (Balb/c, CBA/J, C3H/He, C57BL/-, DBA, NZB/-). CD90.2 is a glycosylphosphatidylinositol (GPI)-anchored membrane glycoprotein involved in signal transduction. CD90.2 is involved in costimulation of lymphocyte proliferation and induction of hematopoietic stem cells differentiation. CD90.2 has been shown to interact with CD45.